FDA issued a Warning Letter to Frontida BioPharm Inc on 8/15/2016 as a result of this inspection.
FDA investigators audited the Frontida BioPharm - Philadelphia, PA, United States facility and issued inspectional observations (via FDA 483) on 17 Jul 2015.
Product details
- Category: Human Drugs
- Inspection end: 17 Jul 2015
- Location: Philadelphia, United States
- FEI: 2523348
